Exploring the Potential of SGLT-2 Inhibitors in Cancer Treatment: Mechanisms, Preclinical Findings, and Clinical Implications

Exploring the Potential of SGLT-2 Inhibitors in Cancer Treatment: Mechanisms, Preclinical Findings, and Clinical Implications

Introduction Sodium-glucose co-transporter 2 (SGLT-2) inhibitors, originally developed for the treatment of type 2 diabetes, have recently attracted attention for their potential applications in oncology. Their potential to modulate tumor metabolism and enhance responses to cancer therapies is an a...

Full description

Saved in:
Bibliographic Details
Main Authors: Aldona Sokołowska, Klaudia Fikas, Kamil Chwaliszewski, Sebastian Samuła, Michał Mazur, Dorota Waz, Jakub Szarłowicz, Zofia Goliszek, Karolina Łucja Sobek, Wiktoria Tabin-Barczak
Format: Article
Language:English
Published: Nicolaus Copernicus University in Toruń 2025-01-01
Series:Quality in Sport
Subjects:
SGLT-2 inhibitors
type 2 diabetes
cardiovascular protection
renal outcomes
athletic performance
cancer therapy
Online Access:https://apcz.umk.pl/QS/article/view/57224
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://apcz.umk.pl/QS/article/view/57224

Similar Items